Studies have shown that the lncRNA SOX2OT is upregulated in temozolomide-resistant and relapsed GBM tissue samples, and its high expression is considered to be closely related to GBM recurrence and poor prognosis. The gene discussed is SOX2-OT; the disease is glioblastoma.